Fact CheckerSign in

NCT07254598Not yet recruiting

Myotensive Extraocular Muscle Techniques Added to Manual Therapy for Migraine Without Aura

Efficacy of Myotensive Techniques Applied to the Extraocular Muscles as an Adjunct to Manual Therapy in the Treatment of Migraine Without Aura

Source: ClinicalTrials.gov · Last updated 28 Nov 2025

Brief summary (registry, in English)

Migraine without aura is a highly prevalent and disabling primary headache that significantly affects quality of life. Many patients experience insufficient symptom control with pharmacological treatments or develop adverse effects, which has increased interest in safe, non-invasive therapeutic alternatives. Physiotherapy, and particularly manual therapy, has shown potential benefits in reducing pain and improving function in headache disorders. This randomized clinical trial will evaluate the effectiveness of adding specific myotensive techniques directed at the extraocular muscles to a craniocervical manual therapy program in adults with migraine without aura. The hypothesis is that targeting the oculomotor system may influence pain modulation and improve symptoms related to visual, cervical, and sensorimotor interactions. Ninety participants aged 18 to 65 years with a medical diagnosis of migraine without aura according to the International Classification of Headache Disorders, Third Edition (ICHD-III), will be randomly assigned to an experimental group or a control group. Both groups will receive six physiotherapy sessions over approximately eight weeks. The experimental group will receive manual therapy on the craniocervical region and temporomandibular joint (TMJ) combined with myotensive techniques for the extraocular muscles, while the control group will receive only the standard manual therapy protocol. Evaluations will be conducted at baseline and post-intervention using validated instruments such as the Migraine Disability Assessment (MIDAS), Craniofacial Pain and Disability Inventory (CF-PDI), Migraine-Specific Quality of Life Questionnaire (MSQ), and Visual Analogue Scale (VAS) for pain. Cervical mobility and oculomotor function will also be assessed through standardized clinical tests. All procedures will be carried out at the Faculty of Nursing, Physiotherapy and Podiatry of the University of Seville. Data will be collected and managed in digital format in compliance with the General Data Protection Regulation (GDPR) and Spanish data protection law. Study results are expected to clarify the role of the oculomotor system in migraine without aura and to determine whether incorporating extraocular myotensive techniques enhances the effects of manual therapy within a comprehensive physiotherapeutic approach.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
84 (estimated)
First submitted
13 Nov 2025
Start date
8 Jan 2026
Primary completion date
Jun 2026
Lead sponsor
Facultad de Enfermería, Fisioterapia y Podología (FEFP)
Diseases
Migraine
NCT number
NCT07254598

What you commit to

  • Study type: Interventional
  • Planned participants: 84
  • From 8 Jan 2026 to the primary completion date, Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving any other type of physiotherapeutic treatment at the time of the intervention.
  • Presenting any of the following conditions: chronic respiratory, cardiovascular, and/or musculoskeletal diseases such as polyarthritis, rheumatic muscle inflammation, osteoporosis, or osteoarthritis; other types of headache, other neurological diseases, oncological processes, cognitive, emotional, or psychological disorders; previous surgical interventions or trauma in the cervical region; or diseases specific to the oculomotor system.

Other

  • Pregnancy or breastfeeding.

Who the study is looking for

  • Being of legal age.
  • Having a medical diagnosis of migraine without aura established by a neurologist, according to the criteria of the ICHD-III
  • Having been diagnosed with migraine for at least one year and experiencing at least one attack per month.
  • Having been prescribed a specific pharmacological treatment by a specialist physician for at least 6 months.
  • Participants must attend all assessments with their habitual optical correction fully updated (glasses or contact lenses), ensuring that any refractive error is appropriately corrected.
  • Presenting symptoms in the oculomotor system, as detailed in the participant information sheet.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universidad from Sevilla
Coordinator of this site? Confirm its status
SevilleSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.